Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The Mexico clinical trials market was valued at USD 379.51 Million in 2025, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.10% during the forecast period of 2026-2035, with the values likely to reach USD 567.19 Million by 2035. The market growth is driven by rising clinical trials in Mexico as they are relatively more affordable than in the United States or Europe, offering a cost advantage without compromising quality.
Market Size and Forecast
- Market Size in 2025: USD 379.51 Million
- Projected Market Size in 2035: USD 567.19 Million
- CAGR from 2026 to 2035: 4.10%
Compound Annual Growth Rate
4.1%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Mexico Clinical Trials Market Overview
Clinical trials are controlled research studies conducted to evaluate the safety, efficacy, and optimal use before regulatory approval and widespread clinical application. According to Regulatory Focus factsheet, Mexico registered around 5,000 clinical studies by April 2024. The clinical trials market in Mexico is growing steadily, driven by a skilled workforce, cost efficiency, diverse patient population, and supportive regulatory environment, making it an attractive location for global pharmaceutical research.
Mexico Clinical Trials Market Growth Drivers
Adoption of Digital Platforms to Promote Ease in Regulatory Approvals
A key growth driver in the Mexico clinical trials market is the recent digital transformation of regulatory processes. In February 2023, the Federal Commission for Protection against Health Risks (Cofepris) launched the Digital Platform for Research and Clinical Trials (Digipris), which enables researchers to submit and manage clinical trial protocols entirely online. By eliminating the need for in-person appointments and physical paperwork, Digipris significantly accelerates approval timelines, enhances transparency, and improves regulatory efficiency, making Mexico a more attractive destination for both domestic and international clinical research sponsors.
Mexico Clinical Trials Market Trends
On 24 July 2026, COFEPRIS and CONBIOÉTICA conducted training for research and ethics committees, healthcare institutions, pharmaceutical and medical-device companies, and other stakeholders on new provisions governing clinical studies. The initiative focused on improving the submission, evaluation, and authorisation of clinical-research protocols. Better regulatory understanding can reduce submission errors and administrative delays, supporting faster trial initiation and strengthening Mexico’s attractiveness for multinational clinical-development programmes.
In June 2026, COFEPRIS announced a reduction in clinical-trial approval timelines from approximately 120 days to 30 days, as part of broader regulatory reforms discussed at Scientific Conference 2026. The shorter pathway is intended to accelerate clinical research and improve regulatory efficiency. Faster approvals can reduce sponsors’ trial start-up costs and timelines, encouraging pharmaceutical and biotechnology companies to initiate more studies in Mexico and increasing demand for CROs, investigators and research sites.
Boehringer Ingelheim announced that it would increase its clinical-research investment in Mexico by 22% during 2026, reaching nearly MXN 200 million. The company planned 23 clinical studies across 177 research institutions, involving approximately 1,400 patients. The expansion directly increases clinical-trial activity across Mexico and supports demand for research centres, investigators, patient recruitment, monitoring, laboratory services and other clinical-trial support capabilities, thereby bolstering the Mexico clinical trials market growth.
Updated COFEPRIS procedures for clinical-trial applications and modifications became effective. The changes formalised a hybrid submission procedure, revised application requirements, removed COFEPRIS approval requirements for certain risk-free research, and introduced an immediate-resolution pathway for selected administrative modifications. Simplified procedures can reduce regulatory friction and improve trial-management efficiency, making Mexico more competitive for sponsors seeking faster study activation and encouraging greater utilisation of local CRO and regulatory-support services.
Digitalisation of Clinical Trial Operations
The Market has been gradually shifting towards an entirely digital process that would involve digital processing of protocols, regulatory documents, patient interaction, data acquisition, data monitoring, and trial management. Digitalisation in regulatory processes is especially essential since the authorities are trying to make the clinical trials process more efficient and less administratively challenging. Electronic documents and remote data gathering may help gain better control and become less dependent on paper-based processes. Additionally, digital health infrastructure allows one to include telemedicine and electronic consent among others into the trials. Digitalisation is expected to improve trial efficiency, shorten administrative timelines, facilitate geographically broader participation, and increase demand for technology-enabled clinical research services, thereby augmenting the Mexico clinical trials demand.
Rising Adoption of Decentralised and Hybrid Trials
Innovations in decentralisation and hybrid clinical trials have increased in importance as sponsors attempt to increase accessibility for patients, while minimising the stress and inconvenience of having to attend research sites on multiple occasions. Such innovations may include a combination of hospital-based tests, as well as telemedicine consultations, remote monitoring, patient reported electronic outcomes, home-based care and communications. The geographical dispersion of a large Mexican population allows for the implementation of these models of clinical trials with participants outside the major metropolitan areas where they typically take place. The increase in the number of decentralised trials would lead to increased recruitment, retention, and demands for remote monitoring services.
Increasing Use of Artificial Intelligence in Clinical Research
Artificial intelligence is fast becoming a valuable resource in various stages of clinical research, from patient identification, data analysis, protocol feasibility, data discrepancy detection, and better decision-making processes. AI-driven methods can assist research teams in processing information effectively while accommodating ever-evolving clinical research models. There have been significant growths of AI-based clinical trials on a global scale, as its applications have reached all areas of diagnostics, predictions, therapy, and data analysis. Wider adoption of AI in Mexico could improve patient-screening efficiency, accelerate data analysis, optimize site selection, and lower operational workloads, encouraging sponsors and research organisations to invest in AI-enabled recruitment, analytics, data-management, and trial-optimisation capabilities.
Stronger Focus on Regulatory Modernisation
Regulatory modernisation is becoming a defining trend in Mexico’s clinical trials environment, with authorities working to simplify procedures, strengthen coordination among regulatory and ethics bodies, and improve the processing of clinical-research applications. Greater alignment between regulatory requirements and contemporary research practices is intended to make study initiation more predictable. Such reforms are particularly relevant for multinational sponsors comparing Mexico with other Latin American research destinations. More efficient regulatory processes can reduce approval uncertainty, shorten study start-up periods, and lower administrative costs. This could improve Mexico’s competitiveness for international trials while supporting expansion of CROs, research sites, regulatory consultants, and clinical-development services, hence boosting the trends in the Mexico clinical trials market.
Expansion of Multinational Pharmaceutical Research Activity
The increasing inclusion of Mexico into global pharmaceutical R&D strategies is due to a number of factors such as its sizable pool of patients, strong healthcare infrastructure, geographic closeness to the US, and the increasing ability to conduct clinical research. It is also experiencing the benefit of a general industry trend towards geographic diversification of clinical trials, driven by the need for access to different patient pools and increased operational robustness. This provides scope for conducting trials in several therapeutic areas and development stages. Continued international participation can increase the number and complexity of clinical studies conducted locally, encouraging investment in investigator networks, specialised research centres, clinical laboratories, patient recruitment, regulatory services, and contract research capabilities.
Mexico Clinical Trials Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Service Type
- Laboratory Services
- Bioanalytical Testing Services
- Cell-Based Assay
- Virology Testing
- Serology, Immunogenicity, & Neutralizing Antibodies
- PK/PD Testing
- Method Development, Optimization & Validation
- Biomarker Testing
- Other Bioanalytical Testing Services
- Decentralized Clinical Trial Services
- Patient Recruitment
- Site Identification
- Analytical Testing Services
- Clinical Trial Supply & Logistic Services
- Protocol Designing
- Clinical Trial Data Management Services
- Medical Device Testing Services
- Other Service
Market Breakup by Therapeutic Areas
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women's Health
- Other Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
- Small Molecules
- Monoclonal Antibodies
- Vaccine
- Cell & Gene Therapy
- Other Applications
Market Breakup by Study Design
- Interventional
- Observational
Market Breakup by Delivery Model
- Full-Service Outsourcing (FSO) Model
- Functional Service Provider (FSP) Model
- Hybrid Model
Market Breakup by End User
- Pharmaceutical & Biopharmaceutical Companies
- Medical Devices Companies
- Academic Institutes
- Other
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Mexico Clinical Trials Market Share
Laboratory Services Projected to Hold Significant Share for Segmentation by Service Type
By service type, the market is categorized into laboratory services, bioanalytical testing services, decentralized clinical trial services, patient recruitment, site identification, analytical testing services, clinical trial supply and logistic services, protocol designing, clinical trial data management services, medical device testing services, and other services. Laboratory services are expected to dominate, owing to their essential function in clinical diagnostics and continuous demand for precise and standardized testing procedures. For instance, in November 2024, UL Solutions Inc., a global leader in applied safety science, expanded its laboratory capacity and capabilities in Mexico to support the rising demand for product safety and performance testing. This move highlights the increasing focus on laboratory and analytical services within Mexico’s clinical trials market, reflecting growing investment in local infrastructure to meet the needs of pharmaceutical and medical device manufacturers across Latin America.
Oncology to Lead the Market Share by Therapeutic Area
According to therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases, women's health, and others. According to the Global Cancer Observatory (2022), Mexico is expected to have over 500,000 five-year prevalent cancer cases, highlighting a significant disease burden. Hence, oncology is projected to lead due to increasing cancer prevalence, rising awareness, and significant investment in research and development of targeted therapies and immuno-oncology treatments.
Leading Players in the Mexico Clinical Trials Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
IQVIA Holdings Inc.
IQVIA is a global leader in advanced analytics and clinical research. In Mexico, the company plays a significant role in the clinical trials market by offering innovative solutions such as Clinical Data Analytics Solutions (CDAS), orchestrated clinical trials, and tech-enabled services. These platforms use artificial intelligence and machine learning to streamline trial oversight, accelerate data processing, and enhance decision-making. IQVIA’s presence supports Mexico’s growing reputation as a strategic hub for efficient, technology-driven clinical research and pharmaceutical development.
Althian Solutions Pvt. Ltd.
Althian is a leading provider of specialized clinical research services. The company plays a vital role in the market by offering comprehensive solutions such as clinical trial supplies management, biomarker and laboratory services, medical writing, and risk management. Known for its regulatory compliance and operational efficiency, Althian supports global firms in conducting successful trials across diverse therapeutic areas.
Parexel International Corporation
Parexel is a global leader in providing comprehensive clinical trial and regulatory services. The company offers solutions across a wide range of therapeutic areas, including oncology, infectious diseases, as well as cell and gene therapies. In Mexico, Parexel plays a crucial role in advancing clinical trials by leveraging its global expertise and local regulatory knowledge to optimize drug development, streamline trials, and ensure efficient market entry. The company’s services are essential for multinational pharmaceutical and biotech companies conducting research in the region.
PPD (Thermo Fisher Scientific)
PPD is a part of Thermo Fisher Scientific, established in 1985 and headquartered in Wilmington, North Carolina. PPD, its clinical research branch plays a significant role in the clinical trials market. Known for digital transformation in clinical development, Thermo Fisher is recognized for its decentralized trials capabilities, diverse patient engagement, and advanced pharmacovigilance solutions. With a focus on improving patient access and trial efficiency, it helps accelerate the development of new medicines, fostering innovation and addressing key challenges like patient diversity and socioeconomic barriers in clinical trials.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Cohortias, Fractals Clinical Research, MCR (Marketing & Clinical Research), Medpace Holdings Inc., SGS de Mexico, and Syneos Health, among others.
Key Questions Answered in the Mexico Clinical Trials Market Report
- What was the Mexico clinical trials market value in 2025?
- What is the Mexico clinical trials market forecast outlook for 2026-2035?
- What are the major factors aiding the Mexico clinical trials market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What is the major Mexico clinical trials market trends?
- Which phase is expected to dominate the market segment?
- Which service type is projected to lead the market segment?
- Which therapeutic area is anticipated to drive the market segment?
- Which application is likely to dominate the market segment?
- Who are the key players involved in the Mexico clinical trials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Pharmaceutical Product |
|
| Breakup by Study Design |
|
| Breakup by Delivery Model |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
